Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University.
Beijing Key Laboratory for HIV/AIDS Research.
AIDS. 2019 Oct 1;33(12):1945-1947. doi: 10.1097/QAD.0000000000002282.
: Reports of resistance to integrase strand transfer inhibitors (INSTIs) are now not uncommon. We analyzed the HIV int gene from plasma of antiretroviral-naïve individuals during acute and chronic HIV-1 infection. No individual with major INSTI mutations was identified. Two individuals harbored INSTI accessory mutations E157Q/T97A were detected for the first time. Our results emphasize the need to consider testing for INSTI resistance at baseline as this class of drugs is increasingly used in clinical routine.
目前已不罕见有整合酶抑制剂(INSTIs)耐药的报告。我们分析了抗逆转录病毒初治个体在急性和慢性 HIV-1 感染期间的 HIV int 基因。未发现具有主要 INSTI 突变的个体。首次发现有 2 名个体携带 INSTI 辅助性突变 E157Q/T97A。我们的研究结果强调需要考虑在基线时进行 INSTI 耐药性检测,因为该类药物在临床常规中使用越来越多。